CRIS Financial Statements

Balance sheet, income statement, cash flow, and dividends for Curis Inc (CRIS).


$25.91M Market Cap.

As of 04/01/2025 5:00 PM ET (MRY) • Disclaimer

CRIS Market Cap. (MRY)


CRIS Shares Outstanding (MRY)


CRIS Assets (MRY)


Total Assets

$41.27M

Total Liabilities

$47.26M

Total Investments

$544.00K

CRIS Income (MRY)


Revenue

$10.91M

Net Income

-$43.39M

Operating Expense

$55.35M

CRIS Cash Flow (MRY)


CF Operations

-$39.56M

CF Investing

$29.44M

CF Financing

$3.44M

CRIS Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

CRIS Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$41,265,000 (-46.60%)

$77,282,000 (-29.00%)

$108,848,000 (-32.93%)

$162,301,000 (-20.58%)

Assets Current

$26,385,000 (-56.68%)

$60,908,000 (-33.88%)

$92,119,000 (-24.72%)

$122,375,000 (-29.16%)

Assets Non-Current

$14,880,000 (-9.12%)

$16,374,000 (-2.12%)

$16,729,000 (-58.10%)

$39,926,000 (26.32%)

Goodwill & Intangible Assets

$8,982,000 (0.00%)

$8,982,000 (0.00%)

$8,982,000 (0.00%)

$8,982,000 (0.00%)

Shareholders Equity

-$5,998,000 (-130.49%)

$19,670,000 (-57.75%)

$46,552,000 (-48.68%)

$90,707,000 (-30.58%)

Property Plant & Equipment Net

$3,394,000 (-2.75%)

$3,490,000 (-31.43%)

$5,090,000 (-18.61%)

$6,254,000 (-13.63%)

Cash & Equivalents

$19,997,000 (-25.05%)

$26,681,000 (35.73%)

$19,658,000 (-50.87%)

$40,014,000 (-69.13%)

Accumulated Other Comprehensive Income

$0 (0%)

$229,000 (223.12%)

-$186,000 (-70.64%)

-$109,000 (-3533.33%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$544,000 (-98.20%)

$30,197,000 (-54.66%)

$66,600,000 (-33.77%)

$100,560,000 (85.32%)

Investments Current

$0 (0%)

$29,653,000 (-55.05%)

$65,965,000 (-13.06%)

$75,870,000 (95.12%)

Investments Non-Current

$544,000 (0.00%)

$544,000 (-14.33%)

$635,000 (-97.43%)

$24,690,000 (60.53%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$3,349,000 (19.86%)

$2,794,000 (-6.08%)

$2,975,000 (-7.72%)

$3,224,000 (5.95%)

Trade & Non-Trade Payables

$3,024,000 (-4.67%)

$3,172,000 (-0.66%)

$3,193,000 (-50.24%)

$6,417,000 (54.03%)

Accumulated Retained Earnings (Deficit)

-$1,239,799,000 (-3.63%)

-$1,196,410,000 (-4.13%)

-$1,148,997,000 (-5.19%)

-$1,092,325,000 (-4.34%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$2,954,000 (5.73%)

$2,794,000 (-29.10%)

$3,941,000 (-21.81%)

$5,040,000 (-34.22%)

Debt Current

$1,336,000 (2.38%)

$1,305,000 (14.37%)

$1,141,000 (67.30%)

$682,000 (-70.19%)

Debt Non-Current

$1,618,000 (8.66%)

$1,489,000 (-46.82%)

$2,800,000 (-35.75%)

$4,358,000 (-18.91%)

Total Liabilities

$47,263,000 (-17.96%)

$57,612,000 (-7.52%)

$62,296,000 (-12.99%)

$71,594,000 (-2.84%)

Liabilities Current

$19,027,000 (40.76%)

$13,517,000 (34.99%)

$10,013,000 (-25.49%)

$13,438,000 (33.33%)

Liabilities Non-Current

$28,236,000 (-35.97%)

$44,095,000 (-15.66%)

$52,283,000 (-10.10%)

$58,156,000 (-8.57%)

CRIS Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$10,908,000 (8.83%)

$10,023,000 (-1.37%)

$10,162,000 (-4.57%)

$10,649,000 (-1.72%)

Cost of Revenue

$98,000 (-53.77%)

$212,000 (-17.51%)

$257,000 (-51.78%)

$533,000 (-0.19%)

Selling General & Administrative Expense

$16,790,000 (-9.96%)

$18,647,000 (-5.09%)

$19,648,000 (13.59%)

$17,297,000 (42.59%)

Research & Development Expense

$38,562,000 (-2.36%)

$39,496,000 (-8.74%)

$43,277,000 (24.06%)

$34,884,000 (51.22%)

Operating Expenses

$55,352,000 (-4.80%)

$58,143,000 (-7.60%)

$62,925,000 (20.59%)

$52,181,000 (48.25%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$43,389,000 (8.49%)

-$47,413,000 (16.34%)

-$56,672,000 (-24.73%)

-$45,436,000 (-51.92%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$43,389,000 (8.49%)

-$47,413,000 (16.34%)

-$56,672,000 (-24.73%)

-$45,436,000 (-51.92%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$43,389,000 (8.49%)

-$47,413,000 (16.34%)

-$56,672,000 (-24.73%)

-$45,436,000 (-51.92%)

Weighted Average Shares

$6,306,284 (19.14%)

$5,293,294 (13.36%)

$4,669,626 (1.99%)

$4,578,458 (88.14%)

Weighted Average Shares Diluted

$6,306,284 (19.14%)

$5,293,294 (13.36%)

$4,669,626 (1.99%)

$4,578,458 (88.14%)

Earning Before Interest & Taxes (EBIT)

-$43,389,000 (8.49%)

-$47,413,000 (16.34%)

-$56,672,000 (-24.73%)

-$45,436,000 (-51.92%)

Gross Profit

$10,810,000 (10.18%)

$9,811,000 (-0.95%)

$9,905,000 (-2.09%)

$10,116,000 (-1.80%)

Operating Income

-$44,542,000 (7.84%)

-$48,332,000 (8.84%)

-$53,020,000 (-26.04%)

-$42,065,000 (-68.95%)

CRIS Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$29,442,000 (-22.08%)

$37,786,000 (14.42%)

$33,023,000 (168.95%)

-$47,895,000 (2.35%)

Net Cash Flow from Financing

$3,437,000 (-54.66%)

$7,580,000 (774.28%)

$867,000 (120.78%)

-$4,172,000 (-102.21%)

Net Cash Flow from Operations

-$39,563,000 (-2.94%)

-$38,434,000 (29.27%)

-$54,337,000 (-44.44%)

-$37,619,000 (-46.16%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$6,684,000 (-196.42%)

$6,932,000 (133.90%)

-$20,447,000 (77.20%)

-$89,686,000 (-178.65%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$29,442,000 (-22.08%)

$37,786,000 (13.00%)

$33,439,000 (169.82%)

-$47,895,000 (0.98%)

Capital Expenditure

$0 (0%)

$0 (0%)

-$416,000 (0%)

$0 (0%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$12,023,000 (-14.83%)

$14,117,000 (141.65%)

$5,842,000 (1847.33%)

$300,000 (-99.84%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$5,927,000 (-1.22%)

$6,000,000 (-11.14%)

$6,752,000 (27.90%)

$5,279,000 (95.66%)

Depreciation Amortization & Accretion

$1,477,000 (-7.63%)

$1,599,000 (14.95%)

$1,391,000 (41.08%)

$986,000 (31.64%)

CRIS Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

99.10% (1.23%)

97.90% (0.41%)

97.50% (2.63%)

95.00% (-0.11%)

Profit Margin

-397.80% (15.90%)

-473.00% (15.19%)

-557.70% (-30.70%)

-426.70% (-54.60%)

EBITDA Margin

-384.20% (15.95%)

-457.10% (15.97%)

-544.00% (-30.33%)

-417.40% (-55.11%)

Return on Average Equity (ROAE)

2909.60% (1819.62%)

-169.20% (-79.43%)

-94.30% (-121.88%)

-42.50% (88.84%)

Return on Average Assets (ROAA)

-88.50% (-61.50%)

-54.80% (-21.24%)

-45.20% (-75.88%)

-25.70% (30.91%)

Return on Sales (ROS)

-397.80% (15.90%)

-473.00% (15.19%)

-557.70% (-30.70%)

-426.70% (-54.60%)

Return on Invested Capital (ROIC)

-869.00% (-703.89%)

-108.10% (-59.44%)

-67.80% (-40.08%)

-48.40% (65.82%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-0.45 (68.73%)

-1.42 (-57.76%)

-0.9 (90.53%)

-9.52 (29.09%)

Price to Sales Ratio (P/S)

1.77 (-73.73%)

6.73 (33.19%)

5.05 (-87.65%)

40.93 (11.26%)

Price to Book Ratio (P/B)

-4.32 (-213.30%)

3.81 (234.77%)

1.14 (-76.31%)

4.81 (30.41%)

Debt to Equity Ratio (D/E)

-7.88 (-369.03%)

2.93 (118.91%)

1.34 (69.58%)

0.79 (39.89%)

Earnings Per Share (EPS)

-6.88 (23.21%)

-8.96 (26.56%)

-12.2 (-22.00%)

-10 (18.03%)

Sales Per Share (SPS)

1.73 (-8.66%)

1.89 (-12.96%)

2.18 (-6.45%)

2.33 (-47.75%)

Free Cash Flow Per Share (FCFPS)

-6.27 (13.59%)

-7.26 (38.07%)

-11.72 (-42.69%)

-8.22 (24.30%)

Book Value Per Share (BVPS)

-0.95 (-125.59%)

3.72 (-62.72%)

9.97 (-49.68%)

19.81 (-63.10%)

Tangible Assets Book Value Per Share (TABVPS)

5.12 (-60.33%)

12.9 (-39.67%)

21.39 (-36.14%)

33.49 (-58.29%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

-1 (0%)

0 (0%)

-9 (43.75%)

Enterprise Value Over EBITDA (EV/EBITDA)

-0.2 (83.09%)

-1.17 (-136.57%)

-0.49 (94.33%)

-8.73 (45.36%)

Asset Turnover

0.22 (91.38%)

0.12 (43.21%)

0.08 (35.00%)

0.06 (-55.56%)

Current Ratio

1.39 (-69.22%)

4.51 (-51.02%)

9.2 (1.02%)

9.11 (-46.87%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$39,563,000 (-2.94%)

-$38,434,000 (29.80%)

-$54,753,000 (-45.55%)

-$37,619,000 (-42.41%)

Enterprise Value (EV)

$8,314,888 (-84.50%)

$53,634,053 (95.97%)

$27,369,098 (-92.95%)

$388,233,625 (-16.70%)

Earnings Before Tax (EBT)

-$43,389,000 (8.49%)

-$47,413,000 (16.34%)

-$56,672,000 (-24.73%)

-$45,436,000 (-51.92%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$41,912,000 (8.52%)

-$45,814,000 (17.13%)

-$55,281,000 (-24.37%)

-$44,450,000 (-52.44%)

Invested Capital

-$3,787,000 (-112.26%)

$30,896,000 (-58.33%)

$74,136,000 (-29.33%)

$104,907,000 (65.60%)

Working Capital

$7,358,000 (-84.47%)

$47,391,000 (-42.28%)

$82,106,000 (-24.63%)

$108,937,000 (-33.03%)

Tangible Asset Value

$32,283,000 (-52.73%)

$68,300,000 (-31.61%)

$99,866,000 (-34.86%)

$153,319,000 (-21.53%)

Market Capitalization

$25,908,888 (-65.46%)

$75,009,053 (41.48%)

$53,019,098 (-87.84%)

$436,059,625 (-9.48%)

Average Equity

-$1,491,250 (-105.32%)

$28,018,750 (-53.36%)

$60,079,000 (-43.85%)

$107,001,250 (1262.51%)

Average Assets

$49,043,750 (-43.32%)

$86,527,250 (-30.95%)

$125,318,750 (-29.02%)

$176,543,250 (119.49%)

Invested Capital Average

$4,993,000 (-88.62%)

$43,870,500 (-47.48%)

$83,531,750 (-10.98%)

$93,836,500 (344.22%)

Shares

8,466,957 (43.92%)

5,883,063 (22.06%)

4,819,918 (5.23%)

4,580,458 (55.75%)